Peppermint Secured $4.7 Million in Seed Funding

The startup raised capital to expand its automated platform for clinical trial financial management.

Updated on Oct. 9, 2026 in Startups

Peppermint Secured $4.7 Million in Seed Funding

Live Poll

Do you believe modern financial automation improves productivity in complex administrative sectors?

Peppermint raised $4.7 million in a seed funding round led by Moxxie. The company provides a platform that helps users automate financial tasks related to clinical trials.

Why it matters

The platform addresses financial inefficiencies in clinical trials by ingesting data from trial management software and cross-referencing it against payment history and contracts.

Early platform adopters have seen revenue collection speeds and overdue invoice reductions improve threefold. Additionally, the software has enabled a 20% reduction in billing staff time.

The players

Peppermint

Peppermint is a technology company that provides financial management automation for clinical trials.

Moxxie

Moxxie is a venture capital firm that led the recent seed funding round for Peppermint.

The details

The platform functions by ingesting data from clinical trial management software to cross-reference payment history against existing contracts. Peppermint plans to use the new capital to expand its capabilities into budget negotiation, expense management, and broader clinical trial analytics.

March 2026: PYMNTS reported on AI agents in healthcare.
May 2026: Publication of the Enterprise AI Benchmark Report.
October 8, 2026: Publication of the article.

Market Landscape

Peppermint is positioning itself within the competitive landscape of health-tech fintech as firms look to replace manual billing processes with AI-driven software. This move follows the trend identified in the 2026 Enterprise AI Benchmark Report toward greater automation in specialized enterprise finance.

Organizations using the platform may see significant reductions in administrative billing overhead and faster revenue cycles. As the company expands its features, current users can expect more integrated tools for budget negotiation and expense management.

The takeaway

Automation in the clinical trial sector can yield measurable improvements in both speed and accuracy for financial operations. Companies that implement these tools can better allocate staff time by shifting focus away from manual invoice reconciliation.